Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Retained Earnings (2021 - 2025)

Roivant Sciences' Retained Earnings history spans 5 years, with the latest figure at $20.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 95.52% year-over-year to $20.6 million; the TTM value through Dec 2025 reached $20.6 million, down 95.52%, while the annual FY2025 figure was $9.4 million, 98.36% down from the prior year.
  • Retained Earnings reached $20.6 million in Q4 2025 per ROIV's latest filing, up from $19.6 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $576.2 million in Q1 2024 to a low of -$4.4 billion in Q3 2023.
  • Average Retained Earnings over 5 years is -$848.8 million, with a median of -$4.6 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: crashed 349352.06% in 2022, then soared 22116.51% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$1.1 million in 2021, then plummeted by 349352.06% to -$3.7 billion in 2022, then soared by 99.26% to -$27.8 million in 2023, then skyrocketed by 1757.07% to $460.4 million in 2024, then tumbled by 95.52% to $20.6 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Retained Earnings are $20.6 million (Q4 2025), $19.6 million (Q3 2025), and -$315.6 million (Q2 2025).